Vaccines
Conference Coverage
ACIP votes unanimously in favor of immunization schedule update and redesign
Conference Coverage
ACIP supports hepatitis A vaccine for homeless individuals
FDA/CDC
FDA expands approval of 9-valent HPV vaccine
Gardasil-9 is now approved for men and women aged 27-45 years.
Conference Coverage
CDC: Trivalent adjuvanted influenza vaccine aIIV3 safe in elderly adults
ATLANTA – Postlicensure surveillance shows no new or unexpected adverse events with aIIV3 (FLUAD).
Article
CDC recommendations for the 2018-2019 influenza season
Vaccines will contain a new A (H3N2) component and B antigen. The live attenuated influenza vaccine returns as an option for those 2- to 49-years...
Latest News
Live attenuated flu vaccine gets ACIP nod for 2018-2019 season
No preferential recommendation is made for one flu vaccine product over another.
Conference Coverage
Norovirus vaccine appears promising in children
MALMO, SWEDEN – High immunogenicity and safety shown in interim analysis of phase 2 trial.
Conference Coverage
ACIP votes to recommend new strains for the 2018-2019 flu vaccine
News
Additional training may be warranted for clinicians administering DTaP
Track record reveals need to reduce vaccine errors.
Conference Coverage
Impact of varicella vaccination on herpes zoster is not what was expected
MALMO, SWEDEN – Real-world data shoot down the exogenous boosting hypothesis.